Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis

Detalles Bibliográficos
Autores principales: Armstrong, April W., Park, Sang Hee, Patel, Vardhaman, Hogan, Malcolm, Wang, Wei-Jhih, Davidson, David, Chirikov, Viktor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613162/
https://www.ncbi.nlm.nih.gov/pubmed/37853229
http://dx.doi.org/10.1007/s13555-023-01043-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613162/
https://www.ncbi.nlm.nih.gov/pubmed/37853229
http://dx.doi.org/10.1007/s13555-023-01043-6

Ejemplares similares